DOCSLIB.ORG

Annals of Oncology Research

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annals of Oncology Research Annals of Oncology Research Guide for authors and workflow Edra S.p.A. Via G. Spadolini 7 Iscrizione al Registro delle 20141 Milano - Italia Imprese di Milano n.2000629 Telefono: +39 02 881841 Partita Iva e C.F. 08056040960 Telefax: +39 02 88184301 Cap. Soc. Euro 329.670,00 IVA [email protected] www.edraspa.it CONDITIONS OF SUBMISSION AND COPYRIGHT ISSUES Manuscripts are considered for publication with the understanding that they do not contain previously published material, have not been published previously and are not currently under review at another journal or elsewhere. All manuscripts must also be accompanied by an adequately compiled and signed Journal Publishing Agreement. If the manuscript is accepted for publication in Annals of Oncology Research, the authors guarantee that it will not be published elsewhere in any other language without permission from the copyright holder. The authors of manuscripts that include illustrations, tables and/or sections of text that have been published previously elsewhere must request permission to reproduce the material from the copyright holder. This permission must be presented in written form during submission of the manuscript. In the absence of such permission, all material received will be regarded as the authors’ own work. Manuscripts that report the results of research conducted on human subjects must include a declaration in the Methods section that the study protocol was approved by the competent Ethics Committee, that the study was conducted in accordance with the ethical standards established in the Declaration of Helsinki of 1946, and that informed consent was obtained from all participants before enrolment in the study. All details that could reveal the identity of a patient (including initials of the patient name and unnecessary reference to personal data such as occupation and residence) must be omitted from the text and illustrative materials. The patients must provide written informed consent to the publication. If experiments have been conducted on animals, the study must have been conducted in accordance with the International Guiding Principles for Biomedical Research Involving Animals guidelines recommended by the World Health Organization (WHO) for the use of laboratory animals, and such adherence must be explicitly stated in the manuscript. PUBLICATION GOAL Time to first decision: approximately: 7 days Acceptance to online publication: 14 days SUBMISSION PROCEDURE To submit the articles each authors needs to register at the official platform: https://www.editorialmanager.com/aor/default.aspx. Then it will be possible to upload the manuscript, that must be in word format and with the word line numbers to facilitate the reviewers. Please, remind that it is a peer revision process, so the title page (with authors' names, their affiliations and the abstract) have to be separated from the rest of the text, starting from the introduction or similar. REVIEW PROCEDURE The decision to publish a manuscript is based on a peer-review process, and acceptance of an article will be based on criteria of originality, relevance, and scientific content of the contribution. Manuscripts are rapidly, strictly and fairly peer reviewed by international experts on our Board of Reviewing Editors and other members of the international community. Edra S.p.A. Via G. Spadolini 7 Iscrizione al Registro delle 20141 Milano - Italia Imprese di Milano n.2000629 Telefono: +39 02 881841 Partita Iva e C.F. 08056040960 Telefax: +39 02 88184301 Cap. Soc. Euro 329.670,00 IVA [email protected] www.edraspa.it Annals of Oncology Research applies a double-blind improved transparent, fair and constructive review process in which both the authors’ and the reviewers’ identities, gender and affiliations are concealed. Research is judged fairly, keeping bias out of the equation. Each manuscript will be thoroughly evaluated by at least two expert referees beyond our editors. Authors may be requested to modify the text based on the comments of reviewers, to which they should respond point by point. We are committed to publishing papers as quickly as possible, while maintaining scientific excellence and rigor. Final articles are published online ahead of issue publication. Statements made in the manuscripts are the responsibility of the author and not of the editor. The opinions expressed in the articles are those of the authors and may not reflect the position of the editors. EDITORIAL WORKFLOW Editorial Office (OE) /Editor in CHief (EIC) /Section Step Comments Editor (SE) 1 Author submits paper 2 EO receives new submission 3 EO executes Technical Check 4 EO initiates discussion EO assigns the manuscript to the EIC. According to Editors discuss the manuscript and decide on: the topic, EIC assigns the manuscript to the - Removal (like "Rejection") 5 appropriate SE (Cancer Epidemiology and Prevention, - Sent back to author: paper returns to author who Cancer Genetics, Epigenetics and non coding RNAs, may revise it and resubmit Genome instability and cancer, Cancer Therapy and - Assignment: paper will be assigned to an editor Precision Medicine, Tumor Heterogeneity and Evolution, Cancer Signalling and Molecular Mechanisms, Cancer Metabolism, Cancer Microbiome, Cancer Inflammation, Microenvironment and Metastasis, Cancer Immunology and immunotherapy, Cancer Therapy and Precision Medicine, Cancer Pharmacology, Cancer chemoprevention, Cancer screening, Cancer Drug discovery and repurposing, Cancer Resistance, Cancer Supporting Care, Modeling Cancer, New Methods in Cancer Research, Cancer Imaging and Radiotherapy, Cancer Clinical Trials, Cancer System Biology, Viruses and cancer, Nutrition and cancer, Palliative care, Cancer and society, Breast cancer, Thoracic cancer, Head and neck cancer, Endocrine The assigned SE will then follow the manuscript in system cancer, Gastrointestinal cancer, Genitourinary the subsequent steps and might require 6 cancer, Gynaecological cancer, Haematological consultation with the EIC or other editorial board cancer, Neurooncology, Paediatric oncology, members for specific issues Sarcoma, Melanoma and skin cancer, Rare cancers, Consultant for Biostatistics, Ethics and science integrity). The SE decides together with the EIC if the submitted Edra S.p.A. Via G. Spadolini 7 Iscrizione al Registro delle 20141 Milano - Italia Imprese di Milano n.2000629 Telefono: +39 02 881841 Partita Iva e C.F. 08056040960 Telefax: +39 02 88184301 Cap. Soc. Euro 329.670,00 IVA [email protected] www.edraspa.it Manuscript should be accepted for further revision or rejected 2 Reviewers (default) or more in case assessment 7 SE identifies and invites the reviewers requires multiple expertise 30 days to review (original manuscripts) Reviewers send in their comments and 8 EO/SE sends reviewers reminders if necessary recommendation 9 SE/EO receives reviewer comments Only assigned editor receives SE decides (revise, accept, reject) and shares its 10 SE makes a recommendation accordingly decision with the EIC. EO receives notification 11 In case of revision, EO notifies the Authors Author submits revision (deadline: 2 months In case of revision, Authors submit revised manuscript 12 default; flexibility depends on the amount of work to EO required to address the editor/reviewer comments) 13 EO assigns manuscript to previous SE 7 days to review (revised manuscripts). Reviewers 14 In case of revision, SE sends revised manuscript to can see comments from authors the Reviewers (if necessary or requested by 15 Reviewers) Reviewers send their recommendation 16 SE receives recommendation Only assigned editor receives SE decides (revise, accept, reject) and shares its 17 SE sets a (final) decision decision with the EIC. EIC confirms. 18 EO notifies the Author 19 EO sets final disposition Publishing editor receives manuscript PREPARATION OF THE MANUSCRIPT Article types Article Description Abstract Word limit Tables/Figures References Research articles Unstructured The text should be Min. 4 Max. 120- Research Articles report on abstract, max. 3000-5500 words (8 Max. 6-8 150 primary research. They must 350 words. to 16 typed, double- describe significant and original spaced pages) not observations. Consideration for including abstract, publication is based on the tables, figures, article’s originality, novelty, and references. scientific soundness, and the appropriateness of its analysis. The article must be subdivided into the following sections: introduction, materials and methods, results, discussion, conclusions. Review article Unstructured The text should be A minimum Max. 150- Reviews are summaries of recent abstract, max. 2000-4000 words number of 3 180. insights in specific research areas 350 words. not including display items of a topic that has direct relevance abstract, tables, is required in the field. Key aims of Reviews figures, references. including are to provide systematic and figures and substantial coverage of mature tables or subjects, evaluations of progress in boxes for specified areas, and/or critical important but assessments of emerging marginal technologies. They should discuss topics. a topic of current interest, outline current knowledge of the subject, analyze different opinions regarding the problem discussed in a balanced manner, be up to date on the latest data in the literature. Normally these are authored by individuals who have themselves made a significant contribution to the original literature on the topic under review and are acknowledged authorities in the field. Brief reports Unstructured
Load more

Recommended publications
  • 28 Practical Dermatology March 2008
    he influence of “the literature” on daily medical ings from a Merck-sponsored study of rofecoxib, alleging that practice is incalculable. Through it, researchers manuscript authors suppressed evidence of cardiac effects caused share and pursue additional avenues of discovery, by the medication. Certainly peer reviewers can assess the infor- while clinicians uncover the latest information mation presented in a publication, but they cannot know what about new patient care strategies. Without pub- relevant information is not presented. Tlished studies documenting the efficacy of new drugs, physicians According to the International Committee of Medical would be hard-pressed to adopt them into practice. Every clini- Journal Editors (ICMJE), a peer-reviewed journal is “one that cian has at some point mined the literature for clues to the diag- submits most of its published research articles for outside nosis or management of a challenging case. The literature can review.” The group of general medical journal editors whose par- even influence insurance coverage decisions, as companies deter- ticipants meet annually and produce the Uniform Requirements mine broad policies and decide case-by-case coverage based on for Manuscripts (URM), acknowledges that, “The number and available published evidence. kind of manuscripts sent for review, the number of reviewers, the It is incumbent upon physicians to keep abreast of the litera- reviewing procedures, and the use made of the reviewers’ opin- ture relevant to their field of practice. Yet familiarity with med- ions may vary. In the interests of transparency, each journal ical journals may breed complacency; those who depend on should publicly disclose its policies in its instructions to these publications may take for granted the quality of informa- authors.” Among US journals, both the Journal of the American tion presented in the canon of the literature while unduly dis- Academy of Dermatology and Archives of Dermatology follow the missing other worthy sources of pertinent, quality information.
    [Show full text]
  • PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 Acta cytologica Karger, Basel 1957 Yes Yes 0001-5547(Print); Yes Indexed (Index 1.562 (Impact (Switzerland) 1938- medicus, Medline, Factor by Thomson 2650(Electronic); Pubmed) Reuters) 0001-5547(Linking) 2 Acta oncologica Informa Healthcare, 1987 No Yes 0284-186X(Print); Yes Indexed (Index 3.730 (Impact London (England) 1651- medicus, Medline, Factor by Thomson 226X(Electronic); Pubmed) Reuters) 0284-186X(Linking) 3 Advances in anatomic pathology Lippincott Williams 1994 Yes Yes 1072-4109(Print); Yes Indexed (Index 2.919 (Impact & Wilkins, 1533- medicus, Medline, Factor by Thomson Hagerstown, MD 4031(Electronic); Pubmed) Reuters) 1072-4109(Linking) 4 American journal of clinical oncology Lippincott Williams 1982 Yes Yes 0277-3732(Print); Yes Indexed (Index 2.977 (Impact & Wilkins, 1537- medicus, Medline, Factor by Thomson Hagerstown, MD 453X(Electronic); Pubmed) Reuters) 0277-3732(Linking) Sl.
    [Show full text]
  • Using Pubmed …For Searching the MEDLINE Database
    UUssiinngg PPuubbMMeedd …for searching the MEDLINE database Available online at http://pubmed.gov A condensed version of the National Training Center and Clearinghouse’s NLM Training: PubMed Compiled by New England Region of the National Network of Libraries of Medicine University of Massachusetts Medical School Worcester, MA Reprints: Phone 800-338-7657 July 2004 Searching MEDLINE PubMed Pubmed.gov 1 Searching MEDLINE PubMed TABLE OF CONTENTS PUBLISHER SUPPLIED CITATIONS ....................................................................................................................4 IN PROCESS CITATIONS........................................................................................................................................5 OTHER PUBLISHER SUPPLIED CITATIONS.....................................................................................................5 MEDLINE & MEDLINE CITATIONS ....................................................................................................................5 OLDMEDLINE CITATIONS ....................................................................................................................................6 PUBMED SIDEBAR ...................................................................................................................................................7 SEARCHING WITH PUBMED ................................................................................................................................8 WHAT IS SEARCHED?.............................................................................................................................................8
    [Show full text]
  • MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 J MOL MICROB BIOTECH, Journal of Basel ; New York : Karger, 1999 Yes e-ISSN: 1660- 1464-1801 Yes Index medicus: 1.701 /Thomson molecular microbiology and biotechnology Switzerland 2412 v1n1,Aug. 1999-; Reuter- Y MEDLINE: v1n1; Aug. 1999-PubMed: v1n1,Aug. 1999- 2 LETT APPL MICROBIOL, Letters in applied Oxford, UK : Published for 1985 Yes Online ISSN: 0266-8254 Yes Index medicus: 1.579/ N microbiology the Society for Applied 1472-765X v26n4,Apr. 1998-; Bacteriology by Blackwell MEDLINE: v26n4,Apr. Scientific Publications, 1998-; PubMed: England v26n4,Apr. 1998- 3 MED MICROBIOL IMMUN, Medical Berlin, New York, 1971 Yes 1432-1831 0300-8584 Yes Index medicus: v157n1, 2.302/ N microbiology and immunology Springer-Verlag, (Electronic) 1971-; MEDLINE: GERMANY v157n1, 1971-; PubMed: v157n1, 1971- 4 METHOD MICROBIOL, Methods in Troy Mo : Academic 1969 Yes 0580-9517 Yes microbiology Press, UNITED STATES 5 MICROB DRUG RESIST, Microbial drug Larchmont, N.Y.
    [Show full text]
  • De Novo Transcriptome Sequencing and Gene Expression Profiling With/Without B-Chromosome Plants of Lilium Amabile Doori Park, Jong-Hwa Kim, Nam-Soo Kim
    www.genominfo.org eISSN 2234-0742 Volume 17 number 3, September 30, 2019 Aims and scope Genomics & Informatics is the official journal of the Korea Genome Organization (http://kogo.or.kr). Its abbreviated title is Genomics Inform. It was launched in 2003 by the Korea Genome Organization. It aims at making a substantial contribution to the understanding of any areas of genomics or informatics. Its scope includes novel data on the topics of gene discovery, comparative genome analyses, molecular and human evolution, informatics, genome structure and function, technological innovations and applications, statistical and mathematical methods, cutting-edge genetic and physical mapping, next generation sequencing and de novo assembly, and other topics that present data where sequence information is used to address biological concerns. Especially, Clinical genomics section is for a short report of all kinds of genome analysis data from clinical field such as cancer, diverse complex diseases and genetic diseases. It encourages submission of the cancer panel analysis data for a single cancer patient or a group of patients. It also encourages deposition of the genome data into designated database. Genome archives section is for a short manuscript announcing the genetic information of recently sequenced prokaryotic and eukaryotic genomes. These genome archives data can make the rationale for sequencing a specific organism. It is published and distributed quarterly at the last dates of March, June, September, and December. All submitted manuscripts will be reviewed and selected for publication after single blind review process. All manuscripts must be submitted online through the e-submission system available from: http://submit.genominfo.org.
    [Show full text]
  • Pubmed: the Bibliographic Database Kathi Canese and Sarah Weis Created: October 9, 2002; Updated: March 20, 2013
    13 PubMed: The Bibliographic Database Kathi Canese and Sarah Weis Created: October 9, 2002; Updated: March 20, 2013. Summary PubMed is a free resource developed and maintained by the National Center for Biotechnology Information (NCBI), a division of the U.S. National Library of Medicine (NLM), at the National Institutes of Health (NIH). PubMed comprises over 22 million citations and abstracts for biomedical literature indexed in NLM’s MEDLINE database, as well as from other life science journals and online books. PubMed citations and abstracts include the fields of biomedicine and health, and cover portions of the life sciences, behavioral sciences, chemical sciences, and bioengineering. PubMed also provides access to additional relevant websites and links to other NCBI resources, including its various molecular biology databases. PubMed uses NCBI's Entrez search and retrieval system. PubMed does not include the full text of the journal article; however, the abstract display of PubMed citations may provide links to the full text from other sources, such as directly from a publisher’s website or PubMed Central (PMC). Data Sources MEDLINE The primary component of PubMed is MEDLINE, NLM’s premier bibliographic database, which contains over 19 million references to journal articles in life sciences, with a concentration on biomedicine. The majority of journals selected for MEDLINE are based on the recommendation of the Literature Selection Technical Review Committee (LSTRC), an NIH-chartered advisory committee of external experts analogous to the committees that review NIH grant applications. Some additional journals and newsletters are selected based on NLM- initiated reviews in areas that are special priorities for NLM or other NIH components (e.g., history of medicine, health services research, AIDS, toxicology and environmental health, molecular biology, and complementary medicine).
    [Show full text]
  • Collaborative Development of Web Tools in R by Peter Kasprzak, Lachlan Mitchell, Olena Kravchuk and Andy Timmins
    CONTRIBUTED RESEARCH ARTICLE 20 Six Years of Shiny in Research - Collaborative Development of Web Tools in R by Peter Kasprzak, Lachlan Mitchell, Olena Kravchuk and Andy Timmins Abstract The use of Shiny in research publications is investigated over the six and a half years since the appearance of this popular web application framework for R, which has been utilised in many varied research areas. While it is demonstrated that the complexity of Shiny applications is limited by the background architecture, and real security concerns exist for novice app developers, the collaborative benefits are worth attention from the wider research community. Shiny simplifies the use of complex methodologies for people of different specialities, at the level of proficiency appropriate for the end user. This enables a diverse community of users to interact efficiently, and utilise cutting edge methodologies. The literature reviewed demonstrates that complex methodologies can be put into practice without insisting on investment in professional training, for a comprehensive understanding from all participants. It appears that Shiny opens up concurrent benefits in communication between those who analyse data and other disciplines, that would enrich much of the peer-reviewed research. Introduction Data is the backbone of research. With the rise of automated data gathering tools, data size and complexity of analysis have driven a growing gap between research disciplines and the required data analysis. Another issue is the fact that different approaches to the same data can compromise validity, as seen in an analysis on effect sizes in observational studies, which found that varied methodological work- flows could reverse conclusions regarding the studied intervention (Donoho, 2017).
    [Show full text]
  • 25Celebrating Years
    Immunohematology Journal of Blood Group Serology and Education Celebrating 25 Years Volume 25, Number 1, 2009 Immunohematology Journal of Blood Group Serology and Education Volume 25, Number 1, 2009 Contents Letter to the Readers 5 Introduction to the 25th anniversary issues G.M. Meny Invited Reviews: Milestones Series 6 Milestones in Immunohematology 1984–2009 D. Mallory Original Report 9 D+ platelet transfusions in D– patients: cause for concern? A.N. Bartley, J.B. Carpenter, and M.P. Berg Case Report 13 Autoantibody formation after alloimmunization inducing bystander immune hemolysis M. Mota, C. Bley, M.G. Aravechia, N. Hamerschlak, A. Sakashita, J.M. Kutner, and L. Castilho Original Report 17 Transfusion of rare cryopreserved red blood cell units stored at –80°C: the French experience T. Peyrard, B.N. Pham, P.Y. Le Pennec and P. Rouger Original Report 22 The polymorphism nt 76 in exon 2 of SC is more frequent in Whites than in Blacks A. Fuchisawa, C. Lomas-Francis, K. Hue-Roye, and M.E. Reid Case Report 24 Nonhemolytic passenger lymphocyte syndrome: donor-derived anti-M in an M+ recipient of a multiorgan transplant A.T. Makuria, A. Langberg, T. Fishbein, and S.G. Sandler Original Report 28 Development and validation of a fluorescent microsphere immunoassay for anti-IgA K.M. Rumilla, J.L. Winters, J.M. Peterman, E.A. Jedynak, and H.A. Homburger In Memoriam 33 Charles Salmon, MD (1925–2009) 35 Announcements 37 Advertisements 41 Instructions for Authors Editors-in-Chief Managing Editor Sandra Nance, MS, MT(ASCP)SBB Cynthia Flickinger, MT(ASCP)SBB Philadelphia, Pennsylvania Philadelphia, Pennsylvania Connie M.
    [Show full text]
  • Future Science Group Catalogue 2019
    Header Future Science Group Catalogue 2019 Contact us Future Science Group Unitec House 2 Albert Place London, N3 1QB United kingdom +44(0)20 8371 6090 [email protected] [email protected] www.future-science-group.com @futuresciencegp future-science-group Future Science Group 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital
    [Show full text]
  • World Allergy Organization Journal
    WORLD ALLERGY ORGANIZATION JOURNAL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 1939-4551 DESCRIPTION . The official pubication of the World Allergy Organization, the World Allergy Organization Journal (WAOjournal) publishes original mechanistic, translational, and clinical research on the topics of allergy, asthma, anaphylaxis, and clincial immunology, as well as reviews, guidelines, and position papers that contribute to the improvement of patient care. WAOjournal publishes research on the growth of allergy prevalence within the scope of single countries, country comparisons, and practical global issues and regulations, or threats to the allergy specialty. The Journal invites the submissions of all authors interested in publishing on current global problems in allergy, asthma, anaphylaxis, and immunology. Of particular interest are the immunological consequences of climate change and the subsequent systematic transformations in food habits and their consequences for the allergy/ immunology discipline. IMPACT FACTOR . 2020: 4.084 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . PubMed Central EDITORIAL BOARD . Joint Editors-in-Chief Alessandro Fiocchi, Bambino Gesu Pediatric Hospital, Rome, Italy Erika Jensen-Jarolim, Medical University of Vienna, Vienna, Austria Regional Editors Luis Caraballo, University of Cartagena, Cartagena, Colombia Nelson Rosário Filho, Federal University of
    [Show full text]
  • Instructions for Authors to See Which Sections Are Compulsory)
    APPENDIX B Instructions for preparation of manuscripts for publication in supplements to BioMed Central journals (available at www.biomedcentral.com/info/authors/instprepdoc) General information | Style and language | Manuscript preparation | Figures | Tables | Additional files | Author presubmission checklist General information Publication Manuscripts accepted by the Editor-in-Chief will be published online in a BioMed Central journal in fully browseable web forms and formatted PDF files. Articles will be available through BioMed Central websites and submitted for inclusion in PubMed. Editorial policies Submission of a manuscript to a BioMed Central journal implies that all authors have read and agreed to its content, and that readily reproducible materials described in the manuscript will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the article. Where appropriate, authors are encouraged to adhere to the standards proposed by the Microarray Gene Expression Data Society (http://www.mged.org) and to deposit microarray data in one of the public repositories. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. The article should not already have been published in another journal or other citeable publication and should not be under consideration by any other journal, but it can already have been deposited on a preprint server. If articles have been published previously as extended abstracts then they must be significantly expanded, include novel methods, results, analysis or interpretation and cite the original abstract.
    [Show full text]
  • A Bibliometric Study of Scientific Literature
    obesity reviews doi: 10.1111/j.1467-789X.2009.00647.x Other Reviews A bibliometric study of scientific literature on obesity research in PubMed (1988–2007)obr_647 603..611 J. Vioque1,2, J. M. Ramos3, E. M. Navarrete-Muñoz1,2 and M. García-de-la-Hera1,2 1Departamento de Salud Pública, Universidad Summary Miguel Hernández, Span; 2CIBER de This article describes a bibliometric review of the publications on obesity research Epidemiología y Salud Pública (CIBERESP), in PubMed over the last 20 years. We used Medline via the PubMed online service Spain; 3Unidad de Enfermedades Infecciosas, of the US National Library of Medicine from 1988 to 2007. The search strategy Servicio de Medicina Interna, Hospital was: ([obesity] in MesH). General Universitario de Elche, Alicante, A total of 58 325 references were retrieved, 25.5% in 1988–1997, and 74.5% Spain in 1998–2007. The growth in the number of publications showed an exponential increase. The references were published in 3613 different journals, with 20 Received 21 May 2009; revised 23 June journals contributing 25% of obesity literature. The two journals contributing 2009; accepted 26 June 2009 most were the International Journal of Obesity (5.1%), Obesity-Obesity Research (2.9%). North America and Europe were the most productive world areas with Address for correspondence: J Vioque, Dpto. 44.1% and 37.9% of the literature, respectively. The US was the predominant Salud Pública, Campus San Juan, country in number of publications, followed by the United Kingdom, Japan and Universidad Miguel Hernandez, Ctra. Valencia Italy. The ranking of production changed when the number of publications was s/n.
    [Show full text]